Can buildings be both carbon and cost-neutral? Lendanger Group founder and CEO Anders Lendager is determined to prove that carbon and cost neutral buildings can and should exist, as Frances Marcellin found out for Design & Build Review.

As Brexit looms and the prospect of a no-deal exit from the European Union becomes ever more real, what challenges lie ahead for the British construction industry? Design & Build Review looks at the issues.

Six months after drone sightings caused chaos at Gatwick Airport, the EU published a new set of rules  addressing safety-related issues and mitigating security risks surrounding their use. Airport Industry Review sums up what drone operators need to do to comply.

A recent roundtable organised by Thales discussed the many challenges and future prospects of using artificial intelligence and autonomous ships. Ship Technology Global reports on the key takeaways from the event.

Greek marine consultancy Ocean Finance is working with partners on SpaceTech4Sea, an innovative project using the aerospace industry’s lightweight LNG tank technology to make the fuel more viable for shipowners. Ship Technology Global finds out more about the project and its benefits from Ocean Finance director Panayotis Zacharioudakis.

French start-up Spacetrain is developing technology for supersonic automated hovertrains which the company hopes will cut travel time, costs and emissions after its launch in 2025. Future Rail speaks to the company’s strategy and development director Thomas Bernin about how the technology works.

The UK Government’s target of reaching net-zero emissions by 2050 is ambitious, with reliance on North Sea oil and a ban on onshore wind farms hamstringing the burgeoning UK renewable industry. Future Power Technology looks at five areas where the UK Government needs to improve over the next three decades to reach this target.

The rise of electric vehicles and emergence of a new middle class in countries like India and China is changing the automotive industry at a much faster pace than ever before, sending shockwaves through the mining world. MINE magazine takes a look at the modern relationship between the two industries.

The majority of antibiotics used globally are also administered to farm animals, and evidence is showing the impact it’s having on the antimicrobial resistance crisis. Pharma Technology Focus finds out how the animal-focused pharma industry feeds into AMR in humans, and what the alternatives are to important shared-use antibiotics. 

Since AI expertise remains limited in the pharma industry, particularly for SMEs without the ability to acquire specialist companies, Chief.ai and Medicines Discovery Catapult have been awarded £370,000 in funding from Innovate UK to support a ‘pay as you go’ style database. Pharma Technology Focus explores how this model can streamline drug discovery and repurposing.

Looking back on a landmark year for HIV treatment that saw breakthrough study results and a successful cure, Pharma Technology Focus looks back at key milestonesin the decades-long quest to effectively prevent, treat and attempt to cure the disease.

5G has been hailed as the next frontier for medicine, introducing new remote surgery capabilities and expanding patient access to the internet in hospitals. But not everyone is convinced. Medical Technology takes a look at the realistic impact that 5G could have on the industry.